These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 494629)

  • 61. Correlation of imaging tests in patient presenting acute pulmonary embolism mimicking inferior myocardial infarction with right ventricular extension.
    García-Ropero Á; Navas Lobato MA; Farré Muncharaz J
    Arch Bronconeumol; 2016 Sep; 52(9):487-8. PubMed ID: 26782076
    [No Abstract]   [Full Text] [Related]  

  • 62. Serum fibrin/fibrinogen degradation products as a prognostic index in acute myocardial infarction.
    Samarendra-Lal-Choudhury ; Edge JR; Stansfield D
    J Clin Pathol; 1975 Oct; 28(10):821-4. PubMed ID: 1214016
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serum fibrin-fibrinogen degradation products after experimental pulmonary embolism.
    Jones DR; Ruckley CV; Owens R; Cash JD
    Br J Surg; 1974 Oct; 61(10):811-3. PubMed ID: 4415741
    [No Abstract]   [Full Text] [Related]  

  • 64. Fibrinolytic activity in coronary heart disease.
    Yao SK; Chen ZJ; Tao SQ
    Chin Med J (Engl); 1989 Sep; 102(9):660-3. PubMed ID: 2517077
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Immunoenzyme determination of fibrin-fibrinogen degradation product levels in acute myocardial infarct patients].
    Grinshteĭn IA; Ignashenkova GV; Kitaev MI
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):18-21. PubMed ID: 3300697
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical value of studying fibrinogen degradation products in patients with ischemic heart disease].
    Ikonnikova EI; Katkova NB; Filippova SB
    Klin Med (Mosk); 1989 May; 67(5):35-6. PubMed ID: 2770207
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Level of fibrinogen/fibrin degradation products (F/FDP) in certain internal diseases].
    Alakhverdian R; Denchev K
    Vutr Boles; 1979; 18(4):28-32. PubMed ID: 494629
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Fibrin/fibrinogen degradation products in the diagnosis of pulmonary thromboembolism].
    Ena IaM; Drannik GN; Konopleva LF
    Ter Arkh; 1985; 57(4):143-6. PubMed ID: 3892752
    [No Abstract]   [Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.